I
Improve Medical Instruments Co Ltd
SZSE:300030
Improve Medical Instruments Co Ltd
SZSE:300030
Price:
4.84 CNY
4.09%
Market Closed
Updated:
May 7, 2024
Section:
Relative Value
The Relative Value of one Improve Medical Instruments Co Ltd stock under the Base Case scenario is 7.13 CNY. Compared to the current market price of 4.84 CNY, Improve Medical Instruments Co Ltd is Undervalued by 32%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Relative Value
Base Case
7.13
CNY
Undervaluation 32%
I
Valuation Multiples
Multiples Across Competitors
Competitors Multiples
Improve Medical Instruments Co Ltd Competitors
Improve Medical Instruments Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
I
|
Improve Medical Instruments Co Ltd
SZSE:300030
|
1.5B CNY | 2.3 | -10.9 | -11.2 | -11.2 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
222B USD | 5.2 | 37 | 22.9 | 33.5 | |
| US |
|
Danaher Corp
NYSE:DHR
|
183.3B USD | 4.2 | 22.7 | 16.5 | 20.4 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
37.3B CHF | 5.6 | 57 | 19.6 | 28.7 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
41.2B USD | 6.1 | 33.3 | 26.6 | 32 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
41.2B USD | 2.8 | 30.3 | 16.5 | 25.6 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
54.9T KRW | 14.9 | 64 | 33.7 | 48.6 | |
| US |
|
West Pharmaceutical Services Inc
NYSE:WST
|
26.8B USD | 9.1 | 47.1 | 32.7 | 39.6 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
26.9B USD | 7.1 | 34.1 | 23.9 | 26.5 | |
| IE |
|
ICON PLC
NASDAQ:ICLR
|
26.1B USD | 3.2 | 38.1 | 17.2 | 26.4 | |
| FR |
|
Sartorius Stedim Biotech SA
PAR:DIM
|
19B EUR | 7 | 74.5 | 32.1 | 52.7 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
